| 腫瘍・血液内科学 | |||||||
| Medical Oncology and Hematology | |||||||
| 整理番号 | 論文の種類 | 著者名 | タイトル・題名 | 雑誌名、書名 | 巻、ページ | 発行年 | DOI |
| 2062001 | 症例報告 | 柳井優花、高野久仁子、長松顕太郎、 坂田真規、片山映樹、吉田奈津美、本田周平、河野利恵、緒方正男、森田泰介、西田欣広、 楢原久司、白尾国昭 |
妊娠19週で発症し、化学療法によって正常分娩に至った急性骨髄性白血病 | 臨床血液 | 61(3):228-233 | 2020 | 10.11406/rinketsu.61.228 |
| 2062002 | 症例報告 | Goto H, Hirano N, Inoue M, Takano K, Ogata M, Kishida T, Arakane M, Daa T, Nishida Y, Suenobu S, Ihara K. | Immune escape by loss of heterozygosis of HLA genes facilitated the transmission of diffuse large B cell lymphoma from mother to offspring. | Br J Haematol. | Jun;189(6):e234-e237. | 2020 | 10.1111/bjh.16662 |
| 2062003 | 原著 | Saburi M, Kondo Y, Ogata M, Soga Y, Abe M, Takano K, Kohno K, Nagai T, Nakayama T. |
Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases. | Int J Hematol. | Nov;112(5):658-665. | 2020 | 10.1007/s12185-020-02957-z |
| 2062004 | 原著 | Ogata M, Kawano R, Satou T, Takata H, Yoshida N, Honda S,
Nagamatsu K, Takano K, Kohno K, Kirihara T, Sato K, Hiroshima Y, Sumi M,
Kurihara T, Takeda W, Ueki T, Kobayashi H. |
Kinetics and clinical significance of human herpesvirus 6 DNA shedding in saliva after allogeneic hematopoietic stem cell transplantation. | Transpl Infect Dis. | Nov 20:e13512. | 2020 | 10.1111/tid.13512. |
| 2062005 | 症例報告 | 長松顕太郎、高野久仁子、高田寛之、 吉田奈津美、佐藤隆子、幸野和洋、緒方正男、白尾国昭 |
同種臍帯血移植後に骨髄壊死を合併したpure erythroid leukemia | 日本造血細胞移植学会雑誌 | 9 (4): 110-116 | 2020 | |
| 2062006 | 原著 | Saburi M, Ogata M, Satou T, Soga Y, Itani K, Kohno K, Kondo Y, Nakayama T. |
Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype. | Int J Hematol. | Jul;112(1):17-23. | 2020 | 10.1007/s12185-020-02871-4 |
| 2062007 | 症例報告 | Saburi M, Ogata M, Soga Y, Satou T, Itani K, Kohno K, Nakayama T. |
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia. | Acta Haematol. | Nov 20:1-6. doi: 10.1159/000511698. | 2020 | 10.1159/000511698 |
| 2062008 | 原著 | Makiyama A, Sukawa Y, Kashiwada T, Kawada J, Hosokawa A,
Horie Y, Tsuji A, Moriwaki T, Tanioka H, Shinozaki K, Uchino K, Yasui H,
Tsukuda H, Nishikawa K, Ishida H, Yamanaka T, Yamazaki K, Hironaka S, Esaki T, Boku N, Hyodo I, Muro K |
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study) | J Clin Oncol. | Jun 10;38(17):1919-1927 | 2020 | 10.1200/JCO.19.03077 |
| 2062009 | 原著 | Hironaka S, Komori A, Machida R, Ito Y, Takeuchi H, Ogawa
G, Kato K, Onozawa M, Minashi K, Yano T, Nakamura K, Tsushima T, Hara H,
Nozaki I, Ura T, Chin K, Fukuda H, Kitagawa Y |
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909 | Esophagus. | Oct;17(4):417-424 | 2020 | 10.1007/s10388-020-00741-w |
| 2062010 | 原著 | Kato K, Doki Y, Ura T, Hamamoto Y, Kojima T, Tsushima T,
Hironaka S, Hara H, Kudo T, Iwasa S, Muro K, Yasui H, Minashi K, Yamaguchi K, Ohtsu A, Kitagawa Y |
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer | Cancer Sci. | May;111(5):1676-1684 | 2020 | 10.1111/cas.14380 |
| 2062011 | 原著 | Hirata K, Hamamoto Y, Ando M, Imamura C, Yoshimura K, Yamazaki K, Hironaka S, Muro K |
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group | BMC Cancer. | Jun 12;20(1):548 | 2020 | 10.1186/s12885-020-07047-1 |
| 2062012 | 原著 | Hosokawa A, Yamazaki K, Matsuda C, Ueda S, Kusaba H, Okamura S, Tsuda M, Tamura T, Shinozaki K, Tsushima T, Tsuda T, Shirakawa T, Yamashita H, Morita S, Hironaka S, Muro K | Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study | Medicine (Baltimore). | Sep 4;99(36):e22060 | 2020 | 10.1097/MD.0000000000022060 |
| 2062013 | 原著 | Miura Y, Ando M, Yamazaki K, Hironaka S, Boku N, Muro K, Hyodo I |
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2) | Support Care Cancer. | Nov 16 Online ahead of print | 2020 | 10.1007/s00520-020-05891-2 |
| 2062014 | 原著 | Sakai D, Taniguchi H, Sugimoto N, Tamura T, Nishina T, Hara
H, Esaki T, Denda T, Sakamoto T, Okuda H, Satoh T, Tsushima T, Makiyama A,
Tsuda T, Hosokawa A, Kuramochi H, Tokunaga S, Moriwaki T, Yasui H, Ishida H,
Tsuji A, Otsu S, Shimokawa H, Baba E, Sato M, Matsumoto S, Ozaki Y, Shinozaki
K, Tamagawa H, Goto M, Kadowaki S, Fujii H, Koh Y, Yamazaki K, Hironaka S, Kishimoto J, Boku N, Hyodo I, Muro K |
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 65) | Eur J Cancer. | Aug;135:11-21 | 2020 | 10.1016/j.ejca.2020.04.014 |
| 2062015 | 原著 | Hirano N, Nishikawa K, Hiratsuka T, Suenobu S, Ihara K | Gastric Carcinoma as Second Malignant Neoplasm in a Survivor From High-risk Neuroblastoma | J Pediatr Hematol Oncol. | Mar;42(2):160-162 | 2020 | 10.1097/MPH.0000000000001409 |
| 2062016 | 原著 | Tsuchiya-Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, Hosokawa S, Morinaga R, Komiya K, Inoue K, Fujita Y, Toyozawa R, Kimura T, Takahashi K, Nishikawa K, Kishimoto J, Nakanishi Y, Okamoto I |
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer | Oncologist. | Jun;25(6):475-e891 | 2020 | 10.1634/theoncologist.2019-0746 |
| 2062017 | 原著 | Mitani S, Kadowaki S, Komori A, Kondoh C, Oze I, Kato K, Masuishi T, Honda K, Narita Y, Taniguchi H, Ando M, Tanaka T, Tajika M, Muro K |
A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies | Adv Ther. | Jun;37(6):2853-2864 | 2020 | 10.1007/s12325-020-01358-2 |
| 2062018 | 原著 | Masuishi T, Taniguchi H, Komori A, Mitani S, Narita Y, Kadowaki S, Ura T, Ando M, Muro K | Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer | Oncologist. | Nov;25(11):e1614-e1620 | 2020 | 10.1634/theoncologist.2020-0463 |